Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
Return-hungry investors are always on thelookout for stocks that can offer value and at the same time promise future growth which remains elusive in most of the companies that have rallied in the past year.
To answer this, Edelweiss Securities in its second edition of Capital Conundrum series, handpicked 20 stocks based on incremental return on capital employed (I-RoCE) framework, which....More>>>
Melrose Industries Plc made a hostile 7.4-billion-pound ($10.2 billion) bid for GKN Plc, taking its offer directly to shareholders of the U.K. maker of aerospace and automotive components after it spurned an unsolicited approach.
The offer values GKN at 430.1 pence a share in cash and stock, Birmingham, England-based Melrose said in a statement Wednesday. GKN last week rejected an initial....More>>>
Small cap generic pharmaceutical stock Lannett Company, Inc (NYSE: LCI) is thesecond most shorted stock on the NYSE with short interest of 55.65% according toHighshortinterest.com. Lannett Company was founded in 1942 anddevelops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications and therapeutic areas. The Company believes its....More>>>
Sometimes I discuss stocks which sit out of my comfort zone, simply because they have a few characteristics which could be of interest to any kind of investor but don’t necessarily fit my portfolio. For example a blue chip stock which has features of positive capital gains combined with interesting dividend. In this case I am talking about Accenture (NYSE:ACN). A little bit more than a year....More>>>
Advertisers spent just 6% more on Twitter (NYSE:TWTR) ads last quarter than they did in the same period a year ago, a decrease from the 18% year-over-year jump seen in the previous quarter. Meanwhile, Facebook (NASDAQ:FB) has seen its ad revenue growth accelerate. Ad revenue increased 59% year over year last quarter, up from 45% growth in the third quarter last year.
I recently bought shares of seven different companies. One of those companies was AbbVie (NYSE:ABBV). I had different reasons for buying each of the stocks. Some were in sectors in which I didn’t already have much exposure in my portfolio. That wasn’t the case with AbbVie, though. I already owned quite a few healthcare stocks and exchange-traded funds (ETFs).
Laboratory Corp. of America (NYSE: LH) and OpGen (NASDAQ:OPGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. <